Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Open-market buy Director bought 395 shares at an average $2.75 ($1,086)
  2. 4 Open-market buy Chairman and CEO bought 395 shares at an average $2.75 ($1,086)
  3. 4 Open-market buy Director bought 2,045 shares at an average $2.74 ($5,605)
  4. 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,485 shares at an average $2.74 ($6,803)
  5. 8-K Event Other events
  6. 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Open-market buy Director bought 2,982 shares at an average $2.72 ($8,112)
  10. 4 Open-market buy Director bought 882 shares at an average $2.72 ($2,399)
  11. 4 Open-market buy Director bought 315 shares at an average $2.72 ($857)
  12. 4 Open-market buy Chairman and CEO bought 315 shares at an average $2.72 ($857)
  13. 4 Open-market buy Director bought 1,785 shares at an average $2.72 ($4,856)
  14. 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,205 shares at an average $2.72 ($5,999)
  15. 8-K Event Material agreement
  16. 4 Open-market buy Director bought 2,982 shares at an average $2.83 ($8,436)
  17. 4 Open-market buy Director bought 882 shares at an average $2.83 ($2,495)
  18. 4 Open-market buy Director bought 315 shares at an average $2.83 ($891)
  19. 4 Open-market buy Chairman and CEO bought 315 shares at an average $2.83 ($891)
  20. 4 Open-market buy Director bought 1,785 shares at an average $2.83 ($5,050)

Page 17 of 52 · 1,039 filings